Article Data

  • Views 207
  • Dowloads 36

Original Research

Open Access

Clinical predictors of treatment success following Gasserian ganglion conventional radiofrequency in trigeminal neuralgia: secondary cohort analysis

  • Mesut Bakır1,*,
  • Kaan Yavuz1
  • Bedri İlcan1
  • Esra Bayburtluoğlu1
  • Şebnem Rumeli1

1Pain Clinic, Department of Anesthesiology and Reanimation, Faculty of Medicine, Mersin University, 33343 Mersin, Türkiye

DOI: 10.22514/jofph.2026.065 Vol.40,Issue 5,September 2026 pp.108-113

Submitted: 10 May 2026 Accepted: 12 August 2026

Published: 12 September 2026

*Corresponding Author(s): Mesut Bakır E-mail: mesutbakir@mersin.edu.tr

Abstract

Background: The study aimed to identify clinical predictors associated with treatment success following Gasserian ganglion conventional radiofrequency (CRF) in patients with trigeminal neuralgia (TN), with particular focus on the predictive value of early clinical response. Methods: This retrospective secondary cohort analysis included 37 patients with classical TN who underwent Gasserian ganglion CRF at a tertiary pain clinic. Treatment success was defined as a ≥50% reduction in Numerical Rating Scale (NRS) score at 6 months compared with baseline. Demographic characteristics, baseline pain severity, trigeminal branch involvement, early post-procedural pain response, complications, additional treatment requirements, and patient satisfaction scores were analyzed. Receiver operating characteristic (ROC) analysis was performed to evaluate the predictive performance of early pain reduction for 6-month treatment success. Results: Twenty-nine patients (78.4%) achieved treatment success at 6 months. The success group demonstrated significantly higher median age (67 vs. 54.5 years, p = 0.006) and baseline pain intensity (NRS0: 10 vs. 8, p = 0.007) compared with the non-success group. Early treatment response at 1 month was strongly associated with 6-month success. Median percentage reduction in NRS score at 1 month was significantly greater in the success group (60% vs. 31.25%, p = 0.008). Achieving ≥50% pain reduction at 1 month was significantly associated with treatment success at 6 months (p = 0.0005). ROC analysis demonstrated good predictive performance for early pain reduction (area under the curve (AUC) = 0.804), with a sensitivity of 82.8%and specificity of 87.5% for the ≥50% cutoff. Patient satisfaction scores were higher among patients with treatment success (p < 0.001). Conclusions: Early post-procedural pain reduction appears to be a clinically useful marker of sustained mid-term treatment success after Gasserian ganglion CRF in TN. In particular, a ≥50% reduction in NRS score at 1 month may help identify patients likely to maintain meaningful pain relief at 6 months.

Keywords

Trigeminal neuralgia; Gasserian ganglion; Conventional radiofrequency; Predictor; Pain relief; Radiofrequency thermocoagulation

Cite and Share

Mesut Bakır, Kaan Yavuz, Bedri İlcan, Esra Bayburtluoğlu, Şebnem Rumeli. Clinical predictors of treatment success following Gasserian ganglion conventional radiofrequency in trigeminal neuralgia: secondary cohort analysis. Journal of Oral & Facial Pain and Headache. 2026; 40(5): 108-113. doi: 10.22514/jofph.2026.065

References

[1] Khawaja SN, Scrivani SJ. Trigeminal neuralgia. Dental Clinics of North America. 2023; 67: 99–115.

[2] Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, et al. European Academy of Neurology guideline on trigeminal neuralgia. European Journal of Neurology. 2019; 26: 831–849.

[3] Zhang X, Peng L, Liu D. Radiofrequency therapies for trigeminal neuralgia: a systematic review and updated meta-analysis. Pain Physician. 2022; 25: E1327–E1337.

[4] Hong T, Ding Y, Yao P. Long-term efficacy and complications of radiofrequency thermocoagulation at different temperatures for the treatment of trigeminal neuralgia. Biochemistry Research International. 2020; 2020: 3854284.

[5] Meng T, Wang K, Tang M, Lin X. The efficacy and prognosis analysis of radiofrequency thermocoagulation and percutaneous balloon compression for recurrent trigeminal neuralgia: a retrospective study. The Korean Journal of Pain. 2026; 39: 373–382.

[6] Nasher AA, Salah K, Al-Zubaidi NA, Al-Haidari SA. Percutaneous radiofrequency thermocoagulation in treating idiopathic trigeminal neuralgia in elderly patients: insights from Yemen’s sole center in Sana’a City. BMC Neurology. 2025; 25: 268.

[7] Zhao W, Yang L, Deng A, Chen Z, He L. Long-term outcomes and predictors of percutaneous radiofrequency thermocoagulation of Gasserian ganglion for maxillary trigeminal neuralgia: a retrospective analysis of 1070 patients with minimum 2-year follow-up. Annals of Medicine. 2022; 54: 2420–2430.

[8] Zheng S, Li X, Li R, Yang L, He L, Cao G, et al. Factors associated with long-term risk of recurrence after percutaneous radiofrequency thermocoagulation of the Gasserian ganglion for patients with trigeminal neuralgia: a multicenter retrospective analysis. The Clinical Journal of Pain. 2019; 35: 958–966.

[9] Bakır M, Türkyılmaz GG, Teker N, Yavuz K, İlcan B, Rumeli Ş. Comparison of Gasserian ganglion conventional radiofrequency ablation and peripheral nerve pulsed radiofrequency in trigeminal neuralgia: a retrospective cohort study. Journal of Oral & Facial Pain and Headache. 2026; 40: 119–126.

[10] Yang CC, Lee MH, Yang JT, Chen KT, Huang WC, Tsai PJ, et al. Percutaneous radiofrequency trigeminal rhizotomy benefits in patients with refractory trigeminal neuralgia. Medicine. 2022; 101: e29543.

[11] Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery. 2001; 48: 524–532; discussion 532–534.

[12] Tang YZ, Jin D, Bian JJ, Li XY, Lai GH, Ni JX. Long-term outcome of computed tomography-guided percutaneous radiofrequency thermocoagulation for classic trigeminal neuralgia patients older than 70 years. Journal of Craniofacial Surgery. 2014; 25: 1292–1295.

[13] Wang Z, Wang Z, Li K, Su X, Du C, Tian Y. Radiofrequency thermocoagulation for the treatment of trigeminal neuralgia. Experimental and Therapeutic Medicine. 2022; 23: 17.

[14] Yildiz G, Akkaya OT. A comparison between the efficacy of trigeminal ganglion radiofrequency thermocoagulation and ultrasound-guided maxillary-mandibular nerve pulsed radiofrequency in the treatment of trigeminal neuralgia: a randomized clinical trial. Cureus. 2024; 16: e61565.

[15] Faizo E, Kurdi M, Hafiz B, Alzahrani W, Alajmi N, Althaqafi B, et al. Patient satisfaction and pain relief following radiofrequency rhizotomy for trigeminal neuralgia: a prospective cohort study. Frontiers in Pain Research. 2025; 6: 1639140.

[16] Worm J, Heinskou TB, Rochat P, Springborg JB, Smilkov EA, Bendtsen L, et al. Five-year prospective outcomes of medical management and microvascular decompression in trigeminal neuralgia. Journal of Neurology. 2025; 272: 701.

[17] Gorgulho A, Agazaryan N, Selch M, Santos BFO, De Salles A. Immediate pain relief elicited after radiosurgery for classical and symptomatic trigeminal neuralgia. Cureus. 2019; 11: e4777.

[18] Mousavi SH, Niranjan A, Huang MJ, Laghari FJ, Shin SS, Mindlin JL, et al. Early radiosurgery provides superior pain relief for trigeminal neuralgia patients. Neurology. 2015; 85: 2159–2165.

JOFPH Volume 40 Issue 5 cover
Current Issue

Vol.40, Issue 5, 12 September 2026

Table of contents
All Issues

Submission Turnaround Time

Top